<DOC>
	<DOC>NCT00520065</DOC>
	<brief_summary>Part A: To compare the glucose and insulin responses of a standard tube feeding product to that of a diabetes-specific tube feeding product in individuals with type 2 diabetes. Part B: To compare the glucose response of a standard tube feeding product to that of a diabetes-specific tube feeding product when consumed by individuals with type 2 diabetes as a sole source of nutrition.</brief_summary>
	<brief_title>Comparison of Nutritional Products for People With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Signed and dated informed consent form Type 2 diabetes 18 to 75 years of age Male or nonpregnant, nonlactating female, at least 6 weeks postpartum If female is of childbearing potential, is practicing birth control BMI greater than or equal to 18.5 kg/m2 and less than 40.0 kg/m2 Medications, such as antihyperglycemic or thyroid medications or hormone therapy, have been maintained at a constant dosage for at least two months prior to screening visit Uses exogenous insulin for glucose control Type 1 diabetes History of diabetic ketoacidosis Current infection; has received corticosteroid treatment in the last 3 months, or has had surgery or received antibiotics in the last 3 weeks Active malignancy Significant cardiovascular event less than 12 weeks prior to study entry End stage organ failure or is status post organ transplant Has an active metabolic, hepatic, or gastrointestinal disease that may interfere with nutrient absorption, distribution, metabolism, or excretion excluding diabetes Chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV Taking any herbals, dietary supplements or medications, other than antihyperglycemic medications during the past four weeks that could profoundly affect blood glucose Fainted or experienced other adverse reactions in response to blood collection prior to this study Has clotting or bleeding disorders Allergic or intolerant to any ingredient found in the study products Participant in a concomitant trial that conflicts with this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>